Clinical Trial Update: Efficacy and Safety of Preoperative Sintilimab Plus Nab-paclitaxel and Cisplatin in BR-ESCC Patients [Phase 2]

View source ↗

Summary

A Phase 2 neoadjuvant trial evaluating the combination of sintilimab with nab-paclitaxel and cisplatin in BR-Esophageal Squamous Cell Carcinoma has completed, a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• CISPLATIN (cisplatin)
• Sintilimab (sintilimab)

Snippet

Sponsor: Sun Yat-Sen University Cancer Center | Conditions: Esophageal Squamous Cell Carcinoma | Phase 2 | Status: COMPLETED